Drug regimen review · Pharmacy Service Deficiencies
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.
F756 in New Jersey. Pick another state for the same tag.
Against expectation — 2025
New Jersey cites F756 more often than its own record predicts
Versus expected share1.51×
1.51 times the share F756 takes of citations nationally.
Share of New Jersey citations1.19%
Of every deficiency written in New Jersey in 2025, this is the portion that was F756.
New Jersey1.19%
National0.79%
Share of all citations that were F756.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What New Jersey surveyors wrote
F756 findings written in New Jersey, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
K · Immediate jeopardy, patternJune 15, 2023
Refer to 760K
Based on observation, interview, record review, and review of pertinent facility documents, it was determined that the facility failed to ensure that the Consultant Pharmacist (CP) recommendations dated 3/7/23 were acted upon in a timely manner regarding the documentation and administration of critical medications, including anticoagulants and insulin medications to prevent serious adverse outcomes for Resident #13, #19 and #20 who required blood sugar monitoring and were dependent on insulin, and Resident #17 and #230 who had physician orders for an anticoagulant to prevent blood clotting. …
Complaint# NJ00174351
Based on interview and record review of pertinent facility documents, it was determined that the facility's Consultant Pharmacist (CP) failed to identify and notify the facility of a medication irregularity for a resident. On 1/11/2024, a nurse documented a Physician order in the medical record for Resident #2 for Warfarin Sodium,( Coumadin) a blood thinner. This medication order was for another resident. Resident #2, was already on a Xarelto, a blood thinner. Resident #2 was administered the Coumadin for eighteen (18) doses from 1/12/2024 to 1/29/2024. On 1/15/2024, the CP conducted an on-site visit and had reviewed Resident #2 chart, however, there was no documented evidence for the recommendations for Coumadin and Xarelto in the report. …
D · No harm, potential for more than minimal, isolatedAugust 7, 2026
Based on observation, interview, record review, and a review of pertinent facility documents, it was determined that the facility's Consultant Pharmacist (CP) failed to identify irregularities for 1 of 5 residents (Resident #9) for unnecessary medications.This deficient practice was evidenced by the following:On 8/3/26 at 6:18 PM, the surveyor observed Resident #9 asleep in bed. On 8/5/26 at 9:55 AM, the surveyor reviewed the hybrid (a combination of paper, scanned, and computer-generated records) medical record of Resident #9, which revealed the following:A review of the face sheet (an admission summary) reflected that Resident #9 was admitted to the facility with diagnoses which included but were not limited to' CVA (cerebrovascular accident also known as stroke) and neurocognitive… …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction